Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 04 Feb 2026 for Allogene Therapeutics, Inc., €53k.
Filing timeline
BuySaleZachary Roberts
Insider track record
Disclosed buys
0
Disclosed sells
4
Signal history
Zachary Roberts: trading record in brief
Zachary Roberts is a declared insider of Allogene Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 9 filings cover trades dated from 20 January 2023 to 2 February 2026.
No open-market purchase appears, only 4 sales worth €166k. The rest of the record consists of 5 share grants. 2026 to date brings no purchases and 2 sales.
Most recently, on 4 February 2026, the filings show an open-market sale worth €53k in Allogene Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Zachary Roberts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
35,700 shares@ US$1.7760.4% of flowCommon StockSEC:0001737287-26-000002:0
26,269 shares@ US$1.5639.6% of flowCommon StockSEC:0001851044-26-000003:0
18,832 shares@ US$1.7020.9% of flowCommon StockSEC:0001737287-25-000016:0
173,913 shares0Common StockSEC:0001737287-25-000006:0
27,199 shares@ US$1.7831.0% of flowCommon StockSEC:0001737287-25-000003:0
140,000 shares0Common StockSEC:0001593968-24-000193:0
24,690 shares@ US$3.174448.1% of flowCommon StockSEC:0001593968-24-000142:0
148,035 shares0Common StockSEC:0001593968-23-000525:0
251,908 shares0Common StockSEC:0001737287-23-000004:0
9 of 9 declarations
